Inosine growth factor shows promise for stroke:
This article was originally published in Clinica
Boston Life Sciences' nerve growth factor Inosine, for treating stroke, can induce nerve fibre growth, stimulate brain rewiring and improve motor functions, an animal study has shown. The findings were published in the Proceedings of the National Academy of Sciences (June 25). Inosine, which so far, appears to have no apparent side effects in animals, has potential as a novel nerve regeneration approach to treatment of stroke and other types of brain injuries, said the Boston, Massachusetts firm.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.